Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02478255 · ClinicalTrials.gov registry record · Phase 2
Longitudinal MR Imaging of Pulmonary Function in Patients Receiving Thoracic Radiation Treatment
A Phase 2 study, sponsored by Bastiaan Driehuys.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT02478255 is a Phase 2 study that has completed, run by Bastiaan Driehuys. The registered enrollment target is 25 participants.
The verdict
NCT02478255, a Phase 2 study, has completed, sponsored by Bastiaan Driehuys.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether magnetic resonance imaging (MRI) using inhaled hyper polarized xenon-129 (129Xe) gas, and conventional contrast can help visualize impaired lung function and detect changes over time in patients receiving treatment as well as those who don't. 129Xe is a special type of xenon gas and when inhaled during MRI may be able to show areas of abnormal thickening of parts of the lungs. These images combined with images taken with injected contrast agents or other special types of MRI such as conventional proton (1H) MRI may provide a better way to look at lung structure and function. The ultimate goal is to predict the degree of radiation-induced lung injury that will develop in a given patient for a given treatment plan. The investigators anticipate that these images will provide more specific information about lung disease than standard lung function tests. The use of 129Xe MRI is investigational. Investigational means that these tests have not yet been approved by the US Food and Drug Administration and are only available in research studies like this one. In addition, standard MRI with contrast is not typically done as standard of care for monitoring changes due to thoracic radiation therapy, therefore, its use in this study is also considered investigational. Healthy volunteers are being asked to participate in this study because to develop a database of functional images that are representative of healthy lungs.
Interventions
- DEVICE MRI
- DRUG Hyperpolarized 129-Xenon gas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-03-21 |
| Est. Completion | 2022-01-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02478255
The ClinicalTrials.gov registry entry for NCT02478255 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bastiaan Driehuys, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.
NCT02478255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02478255 about?
NCT02478255 is a clinical study titled "Longitudinal MR Imaging of Pulmonary Function in Patients Receiving Thoracic Radiation Treatment". The purpose of this study is to determine whether magnetic resonance imaging (MRI) using inhaled hyper polarized xenon-129 (129Xe) gas, and conventional contrast can help visualize impaired lung function and detect changes over time in patients receiving treatment as well as those who don't. 129Xe i...
What is the current status of trial NCT02478255?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2016-03-21. Estimated completion is 2022-01-13.
What interventions are being tested in trial NCT02478255?
The interventions under investigation include: MRI (DEVICE), Hyperpolarized 129-Xenon gas (DRUG).
Who is sponsoring clinical trial NCT02478255?
This trial is sponsored by Bastiaan Driehuys, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.